Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference
-
Nerve localization using peripheral nerve stimulation (PNS) is affected by tissue properties, the anatomy surrounding the nerve, and characteristics of the stimulus waveform. A better understanding of the factors influencing PNS should lead to improved nerve localization techniques for use in regional anesthesia. A finite element approach is described here that includes capacitive effects and accounts for frequency-dependent tissue properties in a computationally efficient manner. The modeling approach can be applied to other bioelectric problems where capacitive effects may be important.
-
Conf Proc IEEE Eng Med Biol Soc · Jan 2009
Clinical TrialA hybrid platform based on EOG and EEG signals to restore communication for patients afflicted with progressive motor neuron diseases.
An efficient alternative channel for communication without overt speech and hand movements is important to increase the quality of life for patients suffering from Amiotrophic Lateral Sclerosis or other illnesses that prevent correct limb and facial muscular responses. Often, such diseases leave the ocular movements preserved for a relatively long time. The aim of this study is to present a new approach for the hybrid system which is based on the recognition of electrooculogram (EOG) and electroencephalogram (EEG) measurements for efficient communication and control. ⋯ A comparison of the performance of the EOG-based system has been made with a BCI system that uses P300 waveforms. As a next step, we plan to integrate EOG and EEG sides. The final goal of the project is to realize a unique noninvasive device able to offer the patient the partial restoration of communication and control abilities with EOG and EEG signals.
-
Conf Proc IEEE Eng Med Biol Soc · Jan 2009
Noninvasive cardiac output estimation using a novel photoplethysmogram index.
Cardiac output (CO) monitoring is essential for indicating the perfusion status of the human cardiovascular system under different physiological conditions. However, it is currently limited to hospital use due to the need for either skilled operators or big, expensive measurement devices. Therefore, in this paper we devise a new CO indicator which can easily be incorporated into existing wearable devices. ⋯ After least squares linear regression, the precision between CO(imp) and CO estimated from IHAR (CO(IHAR)) was 1.40 L/min. The total percentage error of the results was 16.2%, which was well below the clinical acceptance limit of 30%. The results suggest that IHAR is a promising indicator for wearable and noninvasive CO monitoring.
-
Conf Proc IEEE Eng Med Biol Soc · Jan 2009
Pulse rate analysis in case of central sleep apnea: a new algorithm for cardiac rate estimation.
This paper first describes the AM-FM demodulation of an arterial pressure signal. Although it is known to be efficient on signals modulated by breathing, we demonstrate that in case of lack of respiratory modulation (real or simulated central sleep apnea), the AM-FM algorithm doesn't perform well in heart rate extraction. ⋯ The error for cardiac frequency estimation is around 0.2 BPM (Beats Per Minute) versus 5.5 BPM for the AM-FM demodulation. Further experimentations will be performed (with this time both cardiac and respiratory assessments) and will deal with real sleep apnea cases.
-
Conf Proc IEEE Eng Med Biol Soc · Jan 2009
FDA regulation of clinical high intensity focused ultrasound (HIFU) devices.
In the U. S., medical devices are regulated under the authority of the 1976 Medical Device Amendments to the Food, Drug, and Cosmetic Act, with the Food and Drug Administration's Center for Devices and Radiological Health having primary responsibility. The Act defines several regulatory paths to market depending on the complexity of the device and indications for use. ⋯ Pre-clinical testing generally comprises ultrasound power measurements and field characterization, in vitro and in vivo temperature measurements, thermal computational modeling, and demonstrating the accuracy for targeting the region of interest and monitoring treatment progress. Protocols for clinical trials are developed by the device sponsor in conjunction with FDA medical and scientific staff. Currently there are no recognized guidance or standards documents for HIFU testing that could be used in the regulatory review process, but such work is underway within the International Electrotechnical Commission.